Literature DB >> 16381705

Virtual commissioning of a treatment planning system for proton therapy of ocular cancers.

N Koch1, W Newhauser.   

Abstract

The virtual commissioning of a treatment planning system (TPS) for ocular proton beam therapy was performed using Monte Carlo (MC) simulations and a model of a double-scattering ocular treatment nozzle. The simulations produced both the input data required by the TPS and the dose distributions to validate the analytical predictions from the TPS. An MC simulation of a typical ocular melanoma treatment was compared with the TPS predictions, revealing generally good agreement in the absorbed dose distribution. However, in the depth-dose profiles, differences >5% existed in the proximal region of all validation cases considered. Comparison of the radiation coverage at or above the 90% dose level, showed that MC calculated coverage was 82% and 68% of the coverage calculated by the TPS in two planes intersecting the tumour.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16381705     DOI: 10.1093/rpd/nci224

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  18 in total

1.  Assessment of targeting accuracy of a low-energy stereotactic radiosurgery treatment for age-related macular degeneration.

Authors:  Phillip J Taddei; Erik Chell; Steven Hansen; Michael Gertner; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2010-11-12       Impact factor: 3.609

2.  Contribution to Neutron Fluence and Neutron Absorbed Dose from Double Scattering Proton Therapy System Components.

Authors:  A Pérez-Andújar; W D Newhauser; P M Deluca
Journal:  Nucl Technol       Date:  2009-01-01

3.  Monte Carlo and analytical model predictions of leakage neutron exposures from passively scattered proton therapy.

Authors:  Angélica Pérez-Andújar; Rui Zhang; Wayne Newhauser
Journal:  Med Phys       Date:  2013-12       Impact factor: 4.071

4.  Monte Carlo calculations and measurements of absorbed dose per monitor unit for the treatment of uveal melanoma with proton therapy.

Authors:  Nicholas Koch; Wayne D Newhauser; Uwe Titt; Dan Gombos; Kevin Coombes; George Starkschall
Journal:  Phys Med Biol       Date:  2008-02-25       Impact factor: 3.609

5.  Benchmark measurements and simulations of dose perturbations due to metallic spheres in proton beams.

Authors:  Wayne D Newhauser; Laura Rechner; Dragan Mirkovic; Pablo Yepes; Nicholas C Koch; Uwe Titt; Jonas D Fontenot; Rui Zhang
Journal:  Radiat Meas       Date:  2013-11-01       Impact factor: 1.898

6.  Effective Dose from Stray Radiation for a Patient Receiving Proton Therapy for Liver Cancer.

Authors:  Phillip J Taddei; Sunil Krishnan; Dragan Mirkovic; Pablo Yepes; Wayne D Newhauser
Journal:  AIP Conf Proc       Date:  2009-03-10

7.  Maximum proton kinetic energy and patient-generated neutron fluence considerations in proton beam arc delivery radiation therapy.

Authors:  E Sengbusch; A Pérez-Andújar; P M DeLuca; T R Mackie
Journal:  Med Phys       Date:  2009-02       Impact factor: 4.071

8.  Neutron production from beam-modifying devices in a modern double scattering proton therapy beam delivery system.

Authors:  Angélica Pérez-Andújar; Wayne D Newhauser; Paul M Deluca
Journal:  Phys Med Biol       Date:  2009-01-16       Impact factor: 3.609

9.  Assessment of the accuracy of an MCNPX-based Monte Carlo simulation model for predicting three-dimensional absorbed dose distributions.

Authors:  U Titt; N Sahoo; X Ding; Y Zheng; W D Newhauser; X R Zhu; J C Polf; M T Gillin; R Mohan
Journal:  Phys Med Biol       Date:  2008-07-31       Impact factor: 3.609

10.  Reducing stray radiation dose to patients receiving passively scattered proton radiotherapy for prostate cancer.

Authors:  Phillip J Taddei; Jonas D Fontenot; Yuanshui Zheng; Dragan Mirkovic; Andrew K Lee; Uwe Titt; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2008-03-27       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.